INSERM (Institut National de la Santé et de la Recherche Médicale);Université Pierre et Marie Curie (Paris 6);Assistance Publique - Hôpitaux de Paris
发明人:
申请号：
EP12708029.9
公开号：
EP2683395B1
申请日:
2012.03.09
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The present invention relates to novel therapies for treating autoimmune and inflammatory diseases. More specifically, the present invention relates to a use of low dose interleukin-2 for the treatment of type I diabetes and other autoimmune and/or inflammatory diseases.
